Concepedia

Author

DA Berry

The University of Texas MD Anderson Cancer Center

Also Known As

DA Berry

15

Publications

974

Citations

6

H-Index

29

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterUniversity of California, San FranciscoCity Of Hope National Medical CenterCity of HopeDana-Farber Cancer Institute
DB

About

DA Berry is an author at The University of Texas MD Anderson Cancer Center specializing in radiation oncology, cancer research, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

182

2

Health Sciences

1

1

16

3

Public Health

1

1

26

4

Health Informatics

1

1

26

5

Health Law

1

1

26

DA Berry

×

5

Publications

922

Citations

5

H-Index

YearCitations

I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy

AD Barker, C C Sigman, Kelloff Gj,

Clinical Pharmacology & Therapeutics

2009

740

Abstract S2-05: Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast cancer: Outcomes from CALGB 40603 (Alliance)

W. M. Sikov, DA Berry, CM Perou,

Cancer Research

2016

86

Abstract S5-01: Impact of the addition of carboplatin (Cb) and/or bevacizumab (B) to neoadjuvant weekly paclitaxel (P) followed by dose-dense AC on pathologic complete response (pCR) rates in triple-negative breast cancer (TNBC): CALGB 40603 (Alliance)

W. M. Sikov, DA Berry, CM Perou,

Cancer Research

2013

54

The Signature Program: Bringing the Protocol to the Patient

BP Kang, Eric D. Slosberg, Susan Snodgrass,

Clinical Pharmacology & Therapeutics

2015

26

Abstract GS3-08: Pathological complete response predicts event-free and distant disease-free survival in the I-SPY2 TRIAL

Douglas Yee, A. DeMichele, Claudine Isaacs,

Cancer Research

2018

16

Page 1